DEPT OF DEFENSE has floated a tender for Sublingual Immunotherapy (Slit) for U.S. Naval Hospital Yokosuka, Japan. The project location is USA and the tender is closing on 16 May 2024. The tender notice number is HT941024N0065, while the TOT Ref Number is 100735319. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Sublingual Immunotherapy (Slit) for U.S. Naval Hospital Yokosuka, Japan

Deadline : 16 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100735319

Document Ref. No. : HT941024N0065

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEPT OF DEFENSE
Contracting Office Address : FALLS CHURCH, VA 22042
Primary Point of Contact : Marcela Cervantes
marcela.cervantes.civ@health.mil

USA
Email :marcela.cervantes.civ@health.mil

Tender Details

Description

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Markets Contracting Division (WMCD), San Diego, intends to negotiate and award a firm fixed price contract for Sublingual Immunotherapy (SLIT) from Allergy Choices, Inc. in accordance with Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), only one source being available to meet the Government-s needs, to:



Allergy Choices, Inc.

2731 National Dr.

Onalaska, WI 54650-8784



The North American Industry Classification System (NAICS) code for this requirement is 325412 - Pharmaceutical Preparation Manufacturing; the business size standard is 1, 300 employees. The Product Service Code (PSC) is 6505 - Drugs and Biologicals.



The US Naval Hospital Yokosuka provides medical readiness for U.S. Pacific Fleet. Having a dedicated contracted SLIT support for US Naval Hospital Yokosuka will allow uninterrupted operational support for the waterfront.



The objective of this sole source award is to procure SLIT consumables (listed below). Allergy Choices, Inc.

doesn-t have distributors for their products and ship directly to consumers.







Consumables:



Item#

Description

QTY (EA)

Ultimate Delivery Date





Base Year

Inhalant (red) Mult-Allergen

1-20 Antigens One 15Mil Vial (90 Day Sypply)

120

9/30/2025



Option 1

Inhalant (red) Mult-Allergen

1-20 Antigens One 15Mil Vial (90 Day Sypply)

120

9/30/2026





Option 2

Inhalant (red) Mult-Allergen

1-20 Antigens One 15Mil Vial (90 Day Sypply)

120

9/30/2027





Option 3

Inhalant (red) Mult-Allergen

1-20 Antigens One 15Mil Vial (90 Day Sypply)

120

9/30/2028





Option 4

Inhalant (red) Mult-Allergen

1-20 Antigens One 15Mil Vial (90 Day Sypply)

120

9/...
Active Contract Opportunity Notice ID HT941024N0065 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA) Office DEFENSE HEALTH AGENCY
General Information
Contract Opportunity Type: Special Notice (Updated)
All Dates/Times are: (UTC-07:00) PACIFIC STANDARD TIME, LOS ANGELES, USA
Updated Published Date: May 01, 2024 01:45 pm PDT
Original Published Date: May 01, 2024 01:44 pm PDT
Updated Response Date: May 16, 2024 11:00 am PDT
Original Response Date: May 16, 2024 11:00 am PDT
Inactive Policy: 15 days after response date
Updated Inactive Date: May 31, 2024
Original Inactive Date: May 31, 2024
Initiative: None

Classification
Original Set Aside:

Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Place of Performance: Yokosuka, JP-37 JPN

Documents

 Tender Notice

Notice-of-Intent-to-Sole-Source--SLIT.pdf